Blonanserin
It offers improved tolerability as it lacks side effects such as extrapyramidal symptoms, excessive sedation, or hypotension. As a second-generation (atypical) antipsychotic, it is significantly more efficacious in the treatment of the negative symptoms of schizophrenia compared to first-generation (typical) antipsychotics.
| Catalog Number | API132810107 |
| Alternative Name(s) | Lonasen AD-5423 2-(4-ethylpiperazin-1-yl)-4-(4-fluorophenyl)-5,6,7,8,9,10-hexahydrocycloocta[b]pyridine |
| Research Area | Antipsychotic APIs |
| Molecular Formula | C23H30FN3 |
| CAS# | 132810-10-7 |
| SMILES | CCN1CCN(CC1)C2=NC3=C(CCCCCC3)C(=C2)C4=CC=C(C=C4)F |
| Size | inquiry |
| Supplier Page | https://www.protheragen-ing.com/blonanserin-item-12438.html |